Searching PubMed for “Clinical Trial” and checking full-text availability…
for “Clinical Trial” · Showing 101–120 · 2204 ms
Pye S D, Wild S R, McDicken W N, +4 more·The British journal of radiology
Abstract not available
Pryor J P, Blandy J P, Evans P, +2 more·British journal of urology
64 infertile men with oligozoospermia took part in a double blind cross-over trial. Each patient received matching capsules of a placebo and arginine for periods of 12 weeks. There was no difference in the conception rates of the wives or changes in the quality of the semen during each period of treatment.
Goldenberg I S·Cancer
Abstract not available
Viswanathan R, Rao P U, Singh M M, +3 more·The Indian journal of medical research
Abstract not available
Forsythe W I, Merrett J D, Redmond A·The British journal of clinical practice
Abstract not available
Watts T L, Lennon M A, Davies R M·Journal of clinical periodontology
An experimental clinical trial design is described in which the onset of gingival bleeding was used as an indicator of early gingivitis. Twenty-nine dental students participated in a double-blind crossover trial utilising chlorhexidine as a known plaque inhibitor. The onset of gingival bleeding was assessed in three wa…
van Rossum J, Wintzen A R, Endtz L J, +2 more·Annals of neurology
In a double-blind controlled clinical trial on 51 patients with subarachnoid hemorrhage, tranexamic acid, 4 gm per day for ten consecutive days, did not favorably affect the outcome. Neither mortality nor rebleeding rates were improved after a follow-up of three months.
Anscombe A R, Hancock B D, Humphreys W V·Lancet (London, England)
Abstract not available
Bearman J E·American journal of ophthalmology
Abstract not available
Chandra B·Annals of neurology
A double-blind clinical trial of tranexamic acid was carried out on 39 patients with fresh subarachnoid hemorrhage from a ruptured aneurysm. Twenty patients received tranexamic acid, 6 gm daily for 14 to 21 days, while 19 patients received conventional therapy of bedrest and dexamethasone when cerebral edema developed,…
Meyer H M, Parkman P D, Panos T C·The New England journal of medicine
Abstract not available
DeLemos R A, Haggerty R J·Pediatrics
Abstract not available
Salako L A, Falase A O, Aderounmu A F·Current medical research and opinion
A placebo-controlled, double-blind clinical trial of alprenolol was carried out in 20 hypertensive Africans. The active drug and placebo were each administered for 8 weeks using a crossover design. Alprenolol was given in the form of a slow-release tablet preparation at a dosage of 200 mg twice daily. Four patients wer…
Deeley T J·Clinical radiology
Abstract not available
Doran F S·The British journal of surgery
Abstract not available
Cundy J, Scott W·Anaesthesia and intensive care
Abstract not available
Alter M, Greenstein J, Camenga D, +1 more·Neuroepidemiology
The design and course of a placebo-controlled alpha-2 interferon trial in MS patients are described. No beneficial effect of the interferon on the course of MS could be shown.
Simmons F, Goldstein H, Boyle J D·Gastroenterology
Abstract not available
Cherry J D, Bobinski J E, Comerci G D·The Journal of pediatrics
Abstract not available
Bircher J, Bourquin J, Wirth W, +1 more·European journal of clinical pharmacology
Abstract not available